Maze Therapeutics (MAZE) Prepaid Assets (2024 - 2026)
Maze Therapeutics (MAZE) posted Prepaid Assets of $7.4 million for Q1 2026, down 5.17% sequentially from $7.8 million in Q4 2025, and up 38.7% YoY from $5.3 million in Q1 2025.
Analysis
Maze Therapeutics (MAZE) Prepaid Assets (2024 - 2026) Analysis & Trends
Maze Therapeutics has reported Prepaid Assets for 3 years, with the latest figure at $7.4 million in Q1 2026.
- Quarterly Prepaid Assets rose 38.7% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.4 million (up 38.7% YoY) and the FY2025 annual result came in at $7.8 million, up 60.53% from the prior year.
- Prepaid Assets slipped to $7.4 million in Q1 2026 per MAZE's latest filing, from $7.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.8 million in Q4 2025 and troughed at $4.9 million in Q4 2024.
- A 3-year average of $6.6 million and a median of $7.0 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets jumped 60.53% in 2025, then jumped 38.7% in 2026.
- Over 3 years, Prepaid Assets stood at $4.9 million in 2024, then soared by 60.53% to $7.8 million in 2025, then slipped by 5.17% to $7.4 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $7.4 million, $7.8 million, and $7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Maze Therapeutics | 1.55 Bn | 1.55 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.34 Mn |
| Mar 31, 2026 | 7.40 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 6.61 Mn |
| Mar 31, 2025 | 5.33 Mn |
| Dec 31, 2024 | 4.86 Mn |